FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 26.82

Change

-0.07 (-0.26)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-25 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-0.62 (-0.53%)

USD 14.62B
VOT Vanguard Mid-Cap Growth Index ..

-1.16 (-0.48%)

USD 14.29B
IJK iShares S&P Mid-Cap 400 Growth..

-1.11 (-1.20%)

USD 9.84B
XMMO Invesco S&P MidCap Momentum ET..

-0.55 (-0.46%)

USD 2.43B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-1.05 (-0.92%)

USD 1.09B
ETHO Amplify ETF Trust

-0.56 (-0.93%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

-0.40 (-0.58%)

USD 0.17B
IPO Renaissance IPO ETF

-0.31 (-0.72%)

USD 0.15B
BFOR Barron's 400 ETF

-0.66 (-0.92%)

USD 0.15B
PEXL Pacer US Export Leaders ETF

-0.51 (-1.01%)

USD 0.07B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.05% 33% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.05% 27% F 49% F
Trailing 12 Months  
Capital Gain 20.51% 31% F 59% D-
Dividend Return 0.71% 56% F 7% C-
Total Return 21.22% 25% F 52% F
Trailing 5 Years  
Capital Gain -16.27% 6% D- 26% F
Dividend Return 2.68% 33% F 8% B-
Total Return -13.59% 6% D- 17% F
Average Annual (5 Year Horizon)  
Capital Gain -1.90% 6% D- 28% F
Dividend Return -1.23% 6% D- 18% F
Total Return 0.66% 60% D- 15% F
Risk Return Profile  
Volatility (Standard Deviation) 29.54% 19% F 35% F
Risk Adjusted Return -4.18% 6% D- 22% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.